TY - JOUR AU - Buser, Z. AU - Ortega, B. AU - D’Oro, A. PY - 2018 DA - 2018// TI - Spine degenerative conditions and their treatments: national trends in the United States of America JO - Glob Spine J VL - 8 ID - Buser2018 ER - TY - JOUR AU - Rosenthal, N. A. AU - Heinrich, K. H. AU - Chung, J. AU - Yu, H. PY - 2019 DA - 2019// TI - Cost and hospital resource utilization of Staphylococcus aureus infection post elective posterior instrumented spinal fusion surgeries in US Hospitals: a retrospective cohort study JO - Spine (Phila Pa 1976) VL - 44 ID - Rosenthal2019 ER - TY - JOUR AU - Khan, S. N. AU - Cammisa, F. P. AU - Sandhu, H. S. AU - Diwan, A. D. AU - Girardi, F. P. AU - Lane, J. M. PY - 2005 DA - 2005// TI - The biology of bone grafting JO - J Am Acad Orthop Surg VL - 13 ID - Khan2005 ER - TY - JOUR AU - Younger, E. M. AU - Chapman, M. W. PY - 1989 DA - 1989// TI - Morbidity at bone graft donor sites JO - J Orthop Trauma VL - 3 ID - Younger1989 ER - TY - JOUR AU - Lykissas, M. AU - Gkiatas, I. PY - 2017 DA - 2017// TI - Use of recombinant human bone morphogenetic protein-2 in spine surgery JO - World J Orthop VL - 8 ID - Lykissas2017 ER - TY - JOUR AU - Cahill, K. S. AU - Chi, J. H. AU - Day, A. AU - Claus, E. B. PY - 2009 DA - 2009// TI - Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures JO - Jama VL - 302 ID - Cahill2009 ER - TY - JOUR AU - Lao, L. AU - Cohen, J. R. AU - Lord, E. L. AU - Buser, Z. AU - Wang, J. C. PY - 2016 DA - 2016// TI - Trends analysis of rhBMP utilization in single-level posterior lumbar fusion (PLF) in the United States JO - Eur Spine J VL - 25 ID - Lao2016 ER - TY - JOUR AU - Walker, B. AU - Koerner, J. AU - Sankarayanaryanan, S. AU - Radcliff, K. PY - 2014 DA - 2014// TI - A consensus statement regarding the utilization of BMP in spine surgery JO - Curr Rev Musculoskelet Med VL - 7 ID - Walker2014 ER - TY - JOUR AU - Epstein, N. E. PY - 2013 DA - 2013// TI - Complications due to the use of BMP/INFUSE in spine surgery: the evidence continues to mount JO - Surg Neurol Int VL - 4 ID - Epstein2013 ER - TY - JOUR AU - Fu, R. AU - Selph, S. AU - McDonagh, M. PY - 2013 DA - 2013// TI - Effectiveness and harms of recombinant human bone morphogenetic protein-2 in spine fusion: a systematic review and meta-analysis JO - Ann Intern Med VL - 158 ID - Fu2013 ER - TY - STD TI - Zhang H, Wang F, Ding L, et al. A meta analysis of lumbar spinal fusion surgery using bone morphogenetic proteins and autologous iliac crest bone graft. PLoS One. 2014;9(6):e97049. ID - ref11 ER - TY - JOUR AU - Alvin, M. D. AU - Derakhshan, A. AU - Lubelski, D. PY - 2016 DA - 2016// TI - Cost-utility analysis of 1-and 2-level dorsal lumbar fusions with and without recombinant human bone morphogenic protein-2 at 1-year follow-up JO - J Spinal Disord Techn VL - 29 ID - Alvin2016 ER - TY - STD TI - Jain A, Yeramaneni S, Kebaish KM, et al. Cost-utility analysis of rhBMP-2 use in adult spinal deformity surgery. Spine (Phila Pa 1976). 2020;45(14):1009-15. ID - ref13 ER - TY - STD TI - Epstein NE. Pros, cons, and costs of INFUSE in spinal surgery. Surg Neurol Int. 2011;2:10. ID - ref14 ER - TY - JOUR AU - Magnus, M. K. AU - Iceman, K. L. AU - Roukis, T. S. PY - 2018 DA - 2018// TI - Living cryopreserved bone allograft as an adjunct for hindfoot arthrodesis JO - Clin Podiatr Med Surg VL - 35 ID - Magnus2018 ER - TY - JOUR AU - Hall, J. F. AU - McLean, J. B. AU - Jones, S. M. AU - Moore, M. A. AU - Nicholson, M. D. AU - Dorsch, K. A. PY - 2019 DA - 2019// TI - Multilevel instrumented posterolateral lumbar spine fusion with an allogeneic cellular bone graft JO - J Orthop Surg Res VL - 14 ID - Hall2019 ER - TY - STD TI - Corso KA, Etter K, Menzie AM, Bhattacharyya S, Pracyk JB. Characteristics and rate of subsequent lumbar spine fusion surgery among patients treated with allogenic cellular bone matrix for posterior lumbar spinal fusion. Value in Health. 2018;21:S106. ID - ref17 ER - TY - JOUR AU - Birmingham, E. AU - Niebur, G. AU - McHugh, P. E. PY - 2012 DA - 2012// TI - Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche JO - Eur Cells Mater VL - 23 ID - Birmingham2012 ER - TY - JOUR AU - Ghanaati, S. AU - Unger, R. E. AU - Webber, M. J. PY - 2011 DA - 2011// TI - Scaffold vascularization in vivo driven by primary human osteoblasts in concert with host inflammatory cells JO - Biomaterials VL - 32 ID - Ghanaati2011 ER - TY - JOUR AU - Tortelli, F. AU - Tasso, R. AU - Loiacono, F. AU - Cancedda, R. PY - 2010 DA - 2010// TI - The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model JO - Biomaterials VL - 31 ID - Tortelli2010 ER - TY - STD TI - Center for Biologics Evaluation and Research, Center for Devices and Radiological Health, Office of Combination Products. Regulatory considerations for human, cells, tissues, and cellular and tissue-based products: minimal manipulation and homologous use. Guidance for Industry and Food and Drug Administration Staff. In: US Department of Health and Human Services, Food and Drug Administration, eds. December ed 2017. ID - ref21 ER - TY - STD TI - Premier Healthcare Database: Data that informs and performs. 2018. Available at: https://products.premierinc.com/downloads/PremierHealthcareDatabaseWhitepaper.pdf. Accessed September 2018. UR - https://products.premierinc.com/downloads/PremierHealthcareDatabaseWhitepaper.pdf ID - ref22 ER - TY - STD TI - Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130-9. ID - ref23 ER - TY - JOUR AU - Charlson, M. AU - Szatrowski, T. P. AU - Peterson, J. AU - Gold, J. PY - 1994 DA - 1994// TI - Validation of a combined comorbidity index JO - J Clin Epidemiol VL - 47 ID - Charlson1994 ER - TY - JOUR AU - Glassman, S. D. AU - Carreon, L. Y. AU - Campbell, M. J. PY - 2008 DA - 2008// TI - The perioperative cost of Infuse bone graft in posterolateral lumbar spine fusion JO - Spine J VL - 8 ID - Glassman2008 ER - TY - JOUR AU - Glassman, S. D. AU - Carreon, L. Y. AU - Djurasovic, M. PY - 2008 DA - 2008// TI - RhBMP-2 versus iliac crest bone graft for lumbar spine fusion: a randomized, controlled trial in patients over sixty years of age JO - Spine (Phila Pa 1976) VL - 33 ID - Glassman2008 ER - TY - JOUR AU - Safaee, M. M. AU - Dalle Ore, C. L. AU - Zygourakis, C. C. AU - Deviren, V. AU - Ames, C. P. PY - 2019 DA - 2019// TI - Estimating a price point for cost-benefit of bone morphogenetic protein in pseudarthrosis prevention for adult spinal deformity surgery JO - J Neurosurg Spine VL - 30 ID - Safaee2019 ER - TY - STD TI - Medtronic Sofamor Danek USA Inc. Infuse bone graft: instructions for use. 2020. Document #0381204E Rev.D. Available from: http://manuals.medtronic.com/content/dam/emanuals/spinal/0381204E_Infuse_eManual_revD.pdf. Accessed August 2020. UR - http://manuals.medtronic.com/content/dam/emanuals/spinal/0381204E_Infuse_eManual_revD.pdf ID - ref28 ER -